67.52
-1.20
(-1.75%)
As of January 21 at 3:00:01 PM GMT+8. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in CNY | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | -- | 18 | 18 |
| Avg. Estimate | 54.81B | -- | 195.51B | 226.1B |
| Low Estimate | 48.44B | -- | 179.13B | 206.87B |
| High Estimate | 61.19B | -- | 213.86B | 261.96B |
| Year Ago Sales | 42.81B | -- | 175.36B | 195.51B |
| Sales Growth (year/est) | 28.04% | -- | 11.49% | 15.64% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 600309.SS | -- | -- | -- | -- |
| S&P 500 | 9.34% | 11.29% | 14.06% | 13.55% |
Related Tickers
EVK.VI Evonik Industries AG
17.79
+0.62%
ORI.AX Orica Limited
16.95
+1.96%
NVZMY Novonesis A/S
57.40
+3.00%
CRBN.AS Corbion N.V.
23.22
+0.09%
1COV.DE Covestro AG
56.36
+0.04%
AVTX.AS Avantium N.V.
1.8360
-0.33%
GIVN.SW Givaudan SA
3,960.00
-0.08%
WCH.DE Wacker Chemie AG
64.80
-1.43%
VBK.DE Verbio SE
9.52
+4.91%
EMN Eastman Chemical Company
94.38
+1.26%